These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34592659)

  • 1. Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS.
    Wilson S; Croarkin PE; Aaronson ST; Carpenter LL; Cochran M; Stultz DJ; Kozel FA
    J Affect Disord; 2022 Jan; 296():79-88. PubMed ID: 34592659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
    Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
    Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies.
    Sigrist C; Vöckel J; MacMaster FP; Farzan F; Croarkin PE; Galletly C; Kaess M; Bender S; Koenig J
    Eur Child Adolesc Psychiatry; 2022 Oct; 31(10):1501-1525. PubMed ID: 35751003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions.
    d'Andrea G; Mancusi G; Santovito MC; Marrangone C; Martino F; Santorelli M; Miuli A; Di Carlo F; Signorelli MS; Clerici M; Pettorruso M; Martinotti G
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.
    Richieri R; Guedj E; Michel P; Loundou A; Auquier P; Lançon C; Boyer L
    J Affect Disord; 2013 Oct; 151(1):129-35. PubMed ID: 23790811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
    Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
    Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Transcranial Magnetic Stimulation on Cognitive Functioning in Bipolar Depression: A Systematic Review.
    Strelnik A; Strelnik S; Markina E; Zakharov A; Kolsanov A; Smirnova D
    Psychiatr Danub; 2022 Sep; 34(Suppl 8):179-188. PubMed ID: 36170725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
    Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
    Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.
    Perera T; George MS; Grammer G; Janicak PG; Pascual-Leone A; Wirecki TS
    Brain Stimul; 2016; 9(3):336-346. PubMed ID: 27090022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
    Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
    Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of transcranial magnetic stimulation in unipolar depression: A systematic review and meta-analysis of randomized-controlled trials.
    Wang WL; Wang SY; Hung HY; Chen MH; Juan CH; Li CT
    J Affect Disord; 2022 Mar; 301():400-425. PubMed ID: 35032510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case Series Study of Weekly or Fortnightly Transcranial Magnetic Stimulation (TMS) in Major Depressive Disorder.
    Turnier-Shea Y; Peterson GM; Rybak M; Pridmore S
    Brain Sci; 2024 Apr; 14(5):. PubMed ID: 38790394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: A review.
    Rachid F
    Psychiatry Res; 2018 Apr; 262():363-372. PubMed ID: 28951141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation maintenance as a substitute for maintenance electroconvulsive therapy: a case series.
    Cristancho MA; Helmer A; Connolly R; Cristancho P; O'Reardon JP
    J ECT; 2013 Jun; 29(2):106-8. PubMed ID: 23519219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial.
    Wang HN; Wang XX; Zhang RG; Wang Y; Cai M; Zhang YH; Sun RZ; Guo L; Qiao YT; Liu JC; He H; Wang ZH; Wan YC; Tan QR; Zhang ZJ
    Transl Psychiatry; 2017 Dec; 7(12):1292. PubMed ID: 29249805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse prevention (RP) TMS.
    Pridmore S; May T
    Brain Stimul; 2018; 11(6):1391-1392. PubMed ID: 30143418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.